Role of active follow-up for early diagnosis of relapse after elective end of therapies

Abstract

Scheduled follow-up programs failed to detect relapses in 50% of cases presented here. Survival after relapse is not affected by whether relapse was detected at a scheduled or an unscheduled visit.